Home/Filings/3/0001209191-18-004894
3//SEC Filing

NEA 16 GP, LLC 3

Accession 0001209191-18-004894

CIK 0001457612other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:35 PM ET

Size

8.7 KB

Accession

0001209191-18-004894

Insider Transaction Report

Form 3
Period: 2018-01-19
Holdings
  • Warrant to Purchase Common Stock (right to buy)

    Exercise: $1.20From: 2018-01-19Exp: 2023-01-18Common Stock (12,500,000 underlying)
  • Common Stock

    25,000,000
Holdings
  • Warrant to Purchase Common Stock (right to buy)

    Exercise: $1.20From: 2018-01-19Exp: 2023-01-18Common Stock (12,500,000 underlying)
  • Common Stock

    25,000,000
Holdings
  • Common Stock

    25,000,000
  • Warrant to Purchase Common Stock (right to buy)

    Exercise: $1.20From: 2018-01-19Exp: 2023-01-18Common Stock (12,500,000 underlying)
Footnotes (1)
  • [F1]The shares are directly held by New Enterprise Associates 16, L.P. ("NEA 16"), and indirectly held by NEA Partners 16, L.P. ("NEA Partners"), the sole general partner of NEA 16, NEA 16 GP, LLC ("NEA 16 GP"), the sole general partner of NEA Partners 16, and the individual managers of NEA 16 GP (NEA Partners 16, NEA 16 GP and the individual managers of NEA 16 GP, together, the "Indirect Reporting Persons").The individual managers of NEA 16 GP are Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, David M. Mott, Chetan Puttagunta, Jon Sakoda, Scott D. Sandell, Peter W. Sonsini and Ravi Viswanathan. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by NEA 16 in which the Indirect Reporting Persons have no pecuniary interest.

Issuer

GENOCEA BIOSCIENCES, INC.

CIK 0001457612

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001712882

Filing Metadata

Form type
3
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:35 PM ET
Size
8.7 KB